Intraocular metabolic pathways

Intraocular metabolic pathways encompass the complex network of biochemical reactions required to maintain the physiological function and structural integrity of the eye. These pathways include the visual cycle (retinoid cycle) in the retinal pigment epithelium and photoreceptors, aerobic glycolysis (the Warburg effect) in the retina, and the regulation of aqueous humor dynamics (Source: PubMed - PMID: 30141343). The retina is one of the most metabolically active tissues in the body, relying heavily on glucose and oxygen to support phototransduction (Source: NIH - National Eye Institute). Dysregulation of these metabolic processes is a hallmark of several blinding diseases, such as diabetic retinopathy, where glucose metabolism is impaired, and age-related macular degeneration, which involves the accumulation of metabolic waste products like lipofuscin (Source: StatPearls - NBK541032). While not a single drug target, specific enzymes and transporters within these pathways, such as carbonic anhydrase or RPE65, serve as critical points for therapeutic intervention to manage intraocular pressure or slow retinal degeneration (Source: PubMed - PMID: 28603020). Consequently, these pathways represent a broad therapeutic landscape for treating various ocular pathologies.

Other names

Ocular metabolismRetinal metabolic pathwaysIntraocular biochemical pathways

Therapeutic agents modulate specific enzymatic steps or transport processes within the eye, such as inhibiting carbonic anhydrase to reduce aqueous humor production or inhibiting RPE65 to slow the visual cycle and reduce toxic byproduct accumulation.